Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02427074
Other study ID # 1180/09
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date February 1, 2014
Est. completion date August 30, 2019

Study information

Verified date February 2020
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Two percutaneous procedures used in the treatment of idiopathic trigeminal neuralgia are analysed. The effects on pain relief, alterations in cutaneous sensibility and olfactory and salivatory functions are analysed as well.


Description:

Patients diagnosed with idiopathic trigeminal neuralgia, refractory or intolerant to medical treatment, are randomly assigned (after signing a consent form), to receive one of two percutaneous procedures. The patients are evaluated a week before and a week, a month, two months, three months and six months after the surgery.

The questionnaires (Short-Form of the McGill Pain Questionnaire - SF-MPQ, Douleur Neuropathique - DN4, Neuropathic Pain Symptom Inventory - NPSI, Brief Pain Inventory - BPI, Global Clinical Impression - GCI, Hospital Anxiety and Depression - HAD, Brief World Health Organization Quality of Life Questionnaire - WHOQOL-brief, Pain Catastrophizing Scale - PCS) and tests (Quantitative Sensory Testing - QST, olfactory threshold - OT - and discrimination - OD, taste threshold - TT, and salivatory quantification - SQ) are applied as follows:

- Pre-op evaluation: SF-MPQ, DN4, BPI, NPSI, HAD, WHOQOL-brief, PCS, QST, OT, OD, TT, SQ.

- First visit post-op: SF-MPQ, BPI, NPSI, GCI

- Second visit post-op: SF-MPQ, BPI, NPSI, GCI

- Third visit post-op: SF-MPQ, BPI, NPSI, GCI

- Fourth visit post-op: SF-MPQ, DN4, BPI, NPSI, GCI, WHOQOL-brief, HAD, PCS, QST, OT, TT, SQ.

- Fifth visit post-op: SF-MPQ, DN4, BPI, NPSI, GCI, WHOQOL-brief, HAD, PCS, QST, OT, OD, TT, SQ.

Patients with pain recurrence are excluded after the last visit attended. An exploratory analysis is made with 30 patients for a proper sample size calculation during the study.


Recruitment information / eligibility

Status Terminated
Enrollment 33
Est. completion date August 30, 2019
Est. primary completion date March 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Idiopathic Trigeminal Neuralgia

- Refractory/Intolerable medical treatment

- Pain restricted to second or third trigeminal division

Exclusion Criteria:

- Secondary Trigeminal Neuralgia

- Pain restricted to the first trigeminal division

- Refuse to participate

- Unable to comprehend the questionnaires

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Balloon Compression Rhizotomy
The balloon compression rhizotomy is performed in a percutaneous fashion where a Fogarty catheter is positioned in the gasserian ganglion and inflated with 0,7 milliliters of radiopaque dye during 120 seconds.
Radiofrequency Thermal Coagulation Rhizotomy
The gasserian ganglion is submitted to a controlled thermal coagulation with a electrode with 80 Celsius degrees of temperature during 60 seconds on the specific division.

Locations

Country Name City State
Brazil HCFMSUP São Paulo SP

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain relief using numeric rating scale Worst pain in the last 24h scale in the Brief Pain Inventory 6 months
Secondary Changes in how the pain is perceived by the patient assessed by the Short-Form of the McGill Pain Questionnaire Short-Form of the McGill Pain Questionnaire 6 months
Secondary Changes in neuropathic pain quality assessed by Douleur Neuropatique 4 Douleur Neuropatique 4 6 months
Secondary Evaluation of chronic pain and its influence in patients life assessed by Brief Pain Inventory Brief Pain Inventory 6 months
Secondary Changes in types of symptoms of neuropathic pain assessed by Neuropathic Pain Symptom Inventory Neuropathic Pain Symptom Inventory 6 months
Secondary Changes in quality of life assessed by World Health Organization Quality of Life - brief form World Health Organization Quality of Life - brief form 6 months
Secondary Both patient and investigator impression in the treatment assessed by Global Clinical Impression Global Clinical Impression 6 months
Secondary Evaluation of how pain affects patients perception assessed by Pain Catastrophizing Scale Pain Catastrophizing Scale 6 months
Secondary Onset of changes in anxiety or depression assessed by Hospital Anxiety and Depression Hospital Anxiety and Depression 6 months
Secondary Quantification of facial sensibility changes assessed by Quantitative Sensorial Testing Quantitative Sensorial Testing 6 months
Secondary Changes in olfactory threshold assessed by isopropanol solution Olfactory Threshold using isopropanol solution 6 months
Secondary Changes in gustatory threshold assessed using sweet, sour, salty and bitter solutions Gustatory Threshold using sweet, sour, salty and bitter solutions 6 months
Secondary Changes in salivary flow assessed using cotton weights Evaluation of salivary flow using cotton weights 6 months
Secondary Changes in olfactory discrimination assessed using Sniffin' Sticks Using Sniffin' Sticks to evaluate olfactory discrimination 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05152368 - Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy Phase 1
Recruiting NCT02801630 - An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia N/A
Completed NCT02473016 - Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia Phase 2
Recruiting NCT01364259 - A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia Phase 3
Completed NCT01364272 - Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Completed NCT00603694 - Hippocampal Radiation Exposure and Memory N/A
Completed NCT00913107 - Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia Phase 2/Phase 3
Recruiting NCT04996199 - Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial Phase 4
Completed NCT06240494 - Predictive Factors in Maxillary and Mandibular Nerve Radiofrequency Treatment for Trigeminal Neuralgia
Completed NCT05712993 - Comparative Study Between Transcoronoid and Infrazygomatic Anterior Maneuvers N/A
Completed NCT04371575 - Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients
Completed NCT03669744 - Regional Anesthesia in Refractory Trigeminal Neuralgia: 21 Cases Reported to the Limoges University Hospital
Completed NCT05032573 - Feasibility of Olive Oil for Reducing Facial Pain of Trigeminal Neuralgia N/A
Recruiting NCT05615714 - Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial) Phase 1/Phase 2
Recruiting NCT04054024 - Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia Phase 2
Not yet recruiting NCT05451251 - Deep Brain Stimulation for Refractory Trigeminal Neuralgia With a Demyelinating Pontine Lesion N/A
Withdrawn NCT04353505 - Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache Phase 1
Withdrawn NCT01932255 - CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap N/A
Completed NCT05075707 - Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia N/A
Completed NCT06334796 - Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology Early Phase 1